Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The company patent portfolio for Neurotherapeutics Ltd. currently contains 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This workload is handled by 1 distinct examiner, BERTRAM, ERIC D, who is situated in 1 distinct art unit. As the busiest examiner for the portfolio, BERTRAM, ERIC D is responsible for the 1 busiest examiner pending office action. This concentration of 1 pending office action under 1 distinct examiner suggests a highly focused prosecution strategy at this stage.
For a practitioner, the involvement of 1 distinct art unit means that the technical review is confined to a specific niche within Medical Devices & Mechanical Engineering. The outcome of the company's current patent office engagement depends entirely on the 1 busiest examiner pending action. Because only 1 distinct examiner is involved, there is no diversification of examiner perspectives across the portfolio. This profile for Neurotherapeutics Ltd. reflects the current state of its intellectual property development and its focused approach to securing patent rights. Navigating the specific requirements of the assigned official is essential for advancing the case toward allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERTRAM, ERIC D | 1 | 81.3% | +12.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18965903 | NON-INVASIVE BRAIN STIMULATION | BERTRAM, ERIC D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18965903 | NON-INVASIVE BRAIN STIMULATION | BERTRAM, ERIC D | — |
| Art Unit | Apps |
|---|---|
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18965903 | NON-INVASIVE BRAIN STIMULATION | BERTRAM, ERIC D | 3796 | §102 | Final Rejection | — | Pending | Dec 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNeurotherapeutics Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Eric D Bertram has the most, with 1 of Neurotherapeutics Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
